Short-term supplementation of acute long-chain omega-3 polyunsaturated fatty acids may alter depression status and decrease symptomology among young adults with depression: A preliminary randomized and placebo controlled trial

Psychiatry Research

Volumn 229, Issue 1-2, 2015, Pages 485-489

  Ginty, Annie T ^a   Conklin, Sarah M ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b ALLEGHENY COLLEGE   (United States)

Author keywords

Depression; Omega 3 fatty acids; Undergraduates

Indexed keywords

CORN OIL; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; PLACEBO; OMEGA 3 FATTY ACID;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; LOW DRUG DOSE; MALE; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; SUPPLEMENTATION; SYMPTOMATOLOGY; TREATMENT DURATION; UNDERGRADUATE STUDENT; YOUNG ADULT; ADOLESCENT; DEPRESSIVE DISORDER; DIETARY SUPPLEMENT; PERSONALITY TEST; PSYCHOLOGY; PSYCHOMETRY; STATISTICS AND NUMERICAL DATA; STUDENT; UNITED STATES;

ADOLESCENT; ADULT; DEPRESSIVE DISORDER; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; PERSONALITY INVENTORY; PSYCHOMETRICS; STUDENTS; UNITED STATES; YOUNG ADULT;

EID: 84939419156     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.05.072     Document Type: Article

References (49)

1. Active Minds, 2014. The Issue: Student Mental Health. (accessed: 10.20.14), . http://activeminds.org/issues-a-resources/the-issue.
2. American College Health Association American College Health Association-National College Health Assessment II: Reference Group Executive Summary Fall 2011 2012, American College Health Association, Hanover, MD.
3. Antypa N., Van der Does A.J., Smelt A.H., Rogers R.D. Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers. J. Psychopharmacol. 2009, 23:831-840.
4. Appleton K.M., Peters T.J., Hayward R.C., Heatherley S.V., McNaughton S.A., Rogers P.J., Gunnell D., Ness A.R., Kessler D. Depressed mood and n-3 polyunsaturated fatty acid intake from fish: non-linear or confounded association?. Soc. Psychiatry. Epidemiol. 2007, 42:100-104.
5. Barbadoro P., Annino I., Ponzio E., Romanelli R.M., D'Errico M.M., Prospero E., Minelli A. Fish oil supplementation reduces cortisol basal levels and perceived stress: a randomized, placebo-controlled trial in abstinent alcoholics. Mol. Nutr. Food Res. 2013, 57:1110-1114.
6. Beck A.T., Steer R.A., Brown G.K. Manual for the Beck Depression Inventory-II 1996, Psychological Corporation, San Antonio, TX.
7. Beck A.T., Steer R.A., Carbin M.G. Psychometric properties of the beck depression inventory: twenty-five years of evaluation. Clin. Psychol. Rev. 1988, 8:77-100.
8. Calder P.C., Yaqoob P., Harvey D.J., Watts A., Newsholme E.A. Incorporation of fatty acids by concanavalin A-stimulated lymphocytes and the effect on fatty acid composition and membrane fluidity. Biochem. J. 1994, 300:509-518.
9. Chalon S., Delion-Vancassel S., Belzung C., et al. Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. J. Nutr. 1998, 128:2512-2519.
10. Conklin S.M., Gianaros P.J., Brown S.M., Yao J.K., Hariri A.R., Manuck S.B., Muldoon M.F. Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci. Lett. 2007, 421:209-212.
11. Conklin S.M., Manuck S.B., Yao J.K., Flory J.D., Hibbeln J.R., Muldoon M.F. High omega-6 and low omega-4 fatty acids are associated with depressive symptoms and neuroticism. Psychosom. Med. 2007, 69:932-934.
12. Dannehl K., Rief W., Schwarz M.J., Hennings A., Riemer S., Selberdinger V., Stapf T., Euteneuer F. The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression. Neuropsychiatr. Dis. Treat. 2014, 10:1191-1197.
13. Deardorff W.W., Funabiki D. A diagnostic caution in screening depressed college students. Cognit. Ther. Res. 1985, 9:227-284.
14. Demyttenaere K., Bruffaerts R., Posada-Villa J., Gasquet I., Kovess V., Lepine J.P., Angermeyer M.C., Bernert S., de Girolamo G., Morosini P., Polidori G., et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organiation world mental healthy surveys. JAMA 2004, 291:2581-2590.
15. Dozois D.J.A., Dobson K.S., Ahnberg J.L. A psychometric evaluation of the Beck Depression Inventory-II. Psychol. Assess. 1998, 10:83.
16. Drevets W.C., Price J.L., Simpson Jr, Todd R.D., Reich T., Vannier M., Raichle M.E. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997, 386:824-827.
17. Eisenberg D., Gollust S.E., Golberstein E., Hefner J.L. Prevalence and correlates of depression, anxiety, and suicidality among university students. Am. J. Orthopsychiatr. 2007, 77:534-542.
18. Fontani G., Corradeschi F., Felici A., Alfatti F., Migliorini S., Lodi L. Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur. J. Clin. Investig. 2005, 35:691-699.
19. Gallagher, R.P., 2006. National survey counseling center directors 2006. Washington, D.C. International Association of Counseling Services.
20. Gewandter J.S., McDermott M.P., McKeown A., Smith S.M., Williams M.R., Hunsinger M., Farrar J., Turk D.C., Dworkin R.H. Reporting of missing data and methods used to accommodate them in recent analgesic clinical trials: ACTTION systematic review and recommendations. Pain 2014, 155:1871-1877.
21. Ginty A.T., Conklin S.M. Preliminary evidence that acute long-chain omega-3 supplementation reduces cardiovascular reactivity to mental stress: a randomized and placebo controlled trial. Biol. Psychol. 2012, 89:269-272.
22. Grosso G., Pajak A., Marventano S., Castellano S., Galvano F., Bucolo C., Drago F., Carci F. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLOS one 2014, 9:1-18.
23. Grosso G., Galvano F., Marventano S., Malaguarnera M., Bucolo C., Drago F., Caraci F. Omega-3 fatty acids and depression: scientific evidence and biological mechanisms. Oxid. Med. Cell. Longev. 2014, 313570.
24. Heinzel A., Grimm S., Beck J., Schuepbach D., Hell D., Boesiger B., Boeker H., Northoff G. Segregated neural representation of psychological and somatic-vegetative symptoms in severe major depression. Neurosci. Lett. 2009, 456:49-53.
25. Khambaty T., Stewart J.C., Muldoon M.F., Kamarck T.W. Depressive symptom clusters as predictors of 6-year increases in insulin resistance: Data from the Pittsburgh healthy heart project. Psychosom. Med. 2014, 76:363-369.
26. Kiecolt-Glaser J.K., Belury M.A., Andridge R., Malarkey W.B., Glaser R. Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial. Brain Behav. Immun. 2011, 25:1725-1734.
27. Kiecolt-Glaser J.K., Belury M.A., Andridge R., Malarkey W.B., Hwang B.S., Glaser R. Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial. Brain Behav. Immun. 2012, 26:988-995.
28. Kiecolt-Glaser J.K., Belury M.A., Porter K., Beversdorf D.Q., Lemeshow S., Glaser R. Depressive symptoms, omega-6: omega-3 fatty acids, and inflammation in older adults. Psychosom. Med. 2007, 69:217-224.
29. Kupper N., Widdershoven J.W., Pedersen S.S. Cognitive/affective and somatic/affective symptom dimensions of depression are associated with current and future inflammation in heart failure patients. J. Affect. Disord. 2012, 136:567-576.
30. Lin P.Y., Su K.P. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J. Clin. Psychiatry. 2007, 68:1056-1061.
31. Larrieu T., Hilal L.M., Fourrier C., De Smedt-Peyrusse V., Sans N., Capuron L., Laye S. Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behavior through corticosterone secretion. Transl. Psychiatry. 2015, 4:e437. in press, 10.1038/tp.2014.77 issue 4:e437.
32. Leonard B.E. Impact of inflammation on neurotransmitter changes in major depression: an insight into the action of antidepressants. Prog. NeuroPsychopharmacol. Biol. Psychiatry. 2014, 48:261-267.
33. Lucas M., Asselin G., Merette C., Poulin M.J., Dodin S. Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial. Am. J. Clin. Nutr. 2009, 89:641-651.
34. Mayberg H.S. Limbic-cortical dysregulation: a proposed model of depression. J. Neuropsychiatr. Clin. Neurosci. 1997, 9:471-481.
35. Mayberg H.S. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimsied treatment. Br. Med. Bull. 2003, 65:192-207.
36. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., Silva J.A., Tekell J.L., Martin C.C., Lancaster J.L., Fox P.T. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry. 1999, 156:675-682.
37. McNamara R.K., Albe J., Liu Y., et al. Omega-3 fatty acid deficiency during perinatal development increases serotonin turnover in the prefrontal cortex and decreases midbran tryptophan hydroxylase-2 expression in adult female rats: dissociation from estrogenic effects. J. Psychiatry. Res. 2009, 43:656-663.
38. McNamara R.K., Jandacek R., Rider T., Tso P., Cole-Strauss A., Lipton J.W. Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: relationship with central serotonin turnover. Prostaglandins Leukot. Essent. Fat. Acid. 2010, 83:185-191.
39. Nieminen L.R., Makino K.K., Mehta N., Vikkunen M., Kim H.Y., Hibbeln J.R. Relationship between omega-3 fatty acids and plasma neuroactive steroids in alcoholism, depression and controls. Prostaglandins Leukot. Essent. Fat. Acid. 2006, 75:309-314.
40. Nemets B., Stahl Z., Belmaker R.H. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am. J. Psychiatry. 2002, 159:477-479.
41. Raison C.L., Miller A.H. Role of inflammation in depression: implications for phenomenology, pathophysiology and treatment. Mod. Trends Pharmacopsychiatr. 2013, 28:33-48.
42. Rogers P.J., Appleton K.M., Kesller D., Peters T.J., Gunnell D., Hayward R.C., Heatherley S.V., Christian L.M., McNaughton S.A., Ness A.R. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. Br. J. Nutr. 2008, 99:421-431.
43. Shaffer J.A., Edmondson D., Chaplin W.F., Schwartz J.E., Shimbo D., Burg M.M., Rieckmann N., Davidson K.W. Directionality of the relationship between depressive symptom dimensions and C-reactive protein in patients with acute coronary syndromes. Psychosom. Med. 2011, 73:370-377.
44. Smarr K.L., Keefer A.L. Measures of depression and depressive symptoms: Beck Depression Inventory-II, Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety Depression Scale (HADS), Patient Health Questionnaire-9 (PHQ-9). Arthr. Care Res. 2011, S11:S454-S466.
45. Sprinkle S.D., Lurie D., Insko S.L., Atkinson G., Jones G.L., Logan A.R., Bissada N.N. Criterion validity, severity cut scores, and test-retest reliability of the Beck Depression Invenstory-II in a university counseling center sample. J. Couns. Psychol. 2002, 49:381-385.
46. Stewart J.C., Zielke D.J., Hawkins M.A., Williams D.R., Carnethon M.R., Knox S.S., Matthews K.A. Depressive symptom clusters and 5-year incidence of coronary artery calcification: clinical perspective. The coronary artery risk development in young adults study. Circulation 2012, 74:33-38.
47. Su K.P., Huang S.Y., Chiu C.C., Shen W.W. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur. Neuropsychopharmacol. 2003, 13:267-271.
48. World Health Organization, 2012. World Mental Health Day. (accessed: 10.21.14). http://www.who.int/mental_health/management/depression/wfmh_paper_depression_wmhd_2012.pdf.
49. Zanarini M.C., Frankenburg F.R. Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am. J. Psychiatry. 2003, 160:167-169.